Dr. David Rudolph
CEO & Co-Founder
Coordinates scientific and strategic activities with a focus on developing nanoparticle-based drug delivery solutions for our pharmaceutical partners.
-
Leads the development and optimization of (Dual)-Hybrid nanoparticles.
-
Supports partners in evaluating and encapsulating lipophilic and hydrophilic active pharmaceutical ingredients (APIs).
-
Oversees nanoparticle synthesis, characterization, and chemical analysis.
-
Coordinates collaborative R&D projects with pharmaceutical companies and external experts.
-
Develops tailored formulation strategies to improve API stability, solubility, and delivery.
-
Represents NanoDrug Delivery GmbH in scientific, industry, and partner discussions.
Biosketch
Dr. David Rudolph, our managing director, completed his PhD in Chemistry at the Karlsruhe Institute of Technology (KIT) under supervision of Prof. Claus Feldmann, focusing on nanoparticle-based drug-delivery systems and inventing the Dual-Hybrid-NP. During his doctorate, he collaborated with Prof. Frauke Alves, whom he has known for a long time. Since the founding of NanoDrug Delivery GmbH, David has been motivated by the potential to help patients with his research and enjoys learning about business and industrial development. He particularly enjoys guiding the transition from basic research to practical application.
Contact
Driven by the challenge of transforming research into solutions that truly help patients.
Let’s connect to discuss innovation.